- Home
- IKT vs GLDG Comparison
IKT vs GLDG Comparison
Compare IKT & GLDG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IKT
- GLDG
- Stock Information
- Founded
- IKT 2008
- GLDG 2009
- Country
- IKT United States
- GLDG Canada
- Employees
- IKT N/A
- GLDG N/A
- Industry
- IKT Biotechnology: Pharmaceutical Preparations
- GLDG Precious Metals
- Sector
- IKT Health Care
- GLDG Basic Materials
- Exchange
- IKT Nasdaq
- GLDG Nasdaq
- Market Cap
- IKT 140.5M
- GLDG 159.6M
- IPO Year
- IKT 2020
- GLDG N/A
- Fundamental
- Price
- IKT $1.56
- GLDG $1.17
- Analyst Decision
- IKT Buy
- GLDG Strong Buy
- Analyst Count
- IKT 2
- GLDG 1
- Target Price
- IKT $8.00
- GLDG $3.25
- AVG Volume (30 Days)
- IKT 92.1K
- GLDG 1.8M
- Earning Date
- IKT 11-13-2025
- GLDG 10-10-2025
- Dividend Yield
- IKT N/A
- GLDG N/A
- EPS Growth
- IKT N/A
- GLDG N/A
- EPS
- IKT N/A
- GLDG N/A
- Revenue
- IKT N/A
- GLDG N/A
- Revenue This Year
- IKT N/A
- GLDG N/A
- Revenue Next Year
- IKT N/A
- GLDG N/A
- P/E Ratio
- IKT N/A
- GLDG N/A
- Revenue Growth
- IKT N/A
- GLDG N/A
- 52 Week Low
- IKT $1.12
- GLDG $0.71
- 52 Week High
- IKT $4.20
- GLDG $1.34
- Technical
- Relative Strength Index (RSI)
- IKT 42.51
- GLDG 64.16
- Support Level
- IKT $1.50
- GLDG $1.14
- Resistance Level
- IKT $1.73
- GLDG $1.30
- Average True Range (ATR)
- IKT 0.09
- GLDG 0.07
- MACD
- IKT -0.02
- GLDG 0.01
- Stochastic Oscillator
- IKT 17.34
- GLDG 60.47
About IKT Inhibikase Therapeutics Inc.
Inhibikase Therapeutics Inc is a a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson's disease (PD), Parkinson's-related disorders and other diseases of the Abelson Tyrosine Kinases. Its multi-therapeutic pipeline has a primary focus on neurodegeneration and its program utilizing Risvodetinib (also known as IkT-148009), a selective inhibitor of the non-receptor Abelson Tyrosine Kinases, targets the treatment of Parkinson's disease inside and outside the brain as well as other diseases that arise from Abelson Tyrosine Kinases.
About GLDG GoldMining Inc.
GoldMining Inc is a mineral exploration company with a focus on the acquisition, exploration, and development of projects in Colombia, Brazil, the United States, Canada, and Peru. The principal projects are its La Mina Gold project and its Titiribi Gold-Copper project, located in Colombia; Crucero project, located in Peru; Sao Jorge, Batistao, located in Brazil; Yellowknife Gold Project, located in the Northwest Territories, Canada; and various other projects such as Cachoeira, Yarumalito, Whistler, Surubim, Montes Aureos and Trinta, Rea across different locations. The company has two operating segments, with U.S. GoldMining being one distinct operating segment and all other subsidiaries, or Others, being the second operating segment.